Abnormalities of membrane function and lipid metabolism in hypertension: A review

American Journal of Hypertension

Volumn 12, Issue 3, 1999, Pages 315-331

  Zicha, Josef ^a   Kuneš, Jaroslav ^a   Devynck, Marie Aude ^b  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^b Laboratoire de Pharmacologie CNRS URA 1482   (France)

Author keywords

Cholesterol; Cytosolic calcium; Cytosolic pH; HDL; LDL; Membrane microviscosity; Na+ and K+ transport; Phospholipids; Plasma lipids; Triglycerides

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

DYSLIPIDEMIA; ESSENTIAL HYPERTENSION; HUMAN; ION TRANSPORT; LIPID COMPOSITION; LIPID MEMBRANE; LIPID METABOLISM; MEMBRANE TRANSPORT; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; VISCOSITY;

ANIMALS; BLOOD VISCOSITY; CALCIUM; CELL MEMBRANE; CHOLESTEROL, HDL; CHOLESTEROL, LDL; ERYTHROCYTE MEMBRANE; HUMANS; HYDROGEN-ION CONCENTRATION; HYPERTENSION; LIPID METABOLISM; NA(+)-K(+)-EXCHANGING ATPASE; RATS; TRIGLYCERIDES;

EID: 0033104357     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(98)00178-2     Document Type: Review

References (217)

1. Shinitzky M. Membrane fluidity and cellular functions. Shinitzky M., Physiology of Membrane Fluidity. 1984;1-51 CRC Press, Boca Raton.
2. Kinnunen P.K. On the principles of functional ordering in biological membranes. Chem Phys Lipids. 57:1991;375-399.
3. Hunt S.C., Hasstedt S.J., Kuida H., et al. Genetic heritability and common environmental components of resting and stressed blood pressures, lipids, and body mass index in Utah pedigrees and twins. Am J Epidemiol. 129:1989;625-638.
4. Sowers J.R. Impact of lipid and ACE inhibitor therapy on cardiovascular disease and metabolic abnormalities in the diabetic and hypertensive patient. J Hum Hypertens. 11:1997;9-16.
5. Williams R.R., Hunt S.C., Hasstedt S.J., et al. Are there interactions and relations between genetic and environmental factors predisposing to high blood pressure? Hypertension. 18:(suppl I):1991;I29-I37.
6. Henry J.A., Bolla M., Osmond C., et al. The effects of genotype and infant weight on adult plasma levels of fibrinogen, factor VII, and LDL cholesterol are additive. J Med Genet. 34:1997;553-558.
7. Barker D.J. The fetal origins of hypertension. J Hypertens. 14:(suppl 5):1996;S117-S120.
8. Hales C.N., Barker D.J., Clark P.M., et al. Fetal and infant growth and impaired glucose tolerance at age 64. Br Med J. 303:1991;1019-1022.
9. Fall C.H., Barker D.J., Osmond C., et al. Relation of infant feeding to adult serum cholesterol concentration and death from ischaemic heart disease. Br Med J. 304:1992;801-805.
10. Fall C.H., Osmond C., Barker D.J., et al. Fetal and infant growth and cardiovascular risk factors in women. Br Med J. 310:1995;428-432.
11. Koldovsky O., Hahn P., Hromadová M., et al. Late effects of early nutritional manipulations. Physiol Res. 44:1995;357-360.
12. Lucas A., Baker B.A., Desai M., Hales C.N. Nutrition in pregnant or lactating rats programs lipid metabolism in the offspring. Br J Nutr. 76:1996;605-612.
13. Langley-Evans S.C. Hypertension induced by foetal exposure to a maternal low-protein diet, in the rat, is prevented by pharmacological blockade of maternal glucocorticoid synthesis. J Hypertens. 15:1997;537-544.
14. Langley-Evans S.C. Intrauterine programming of hypertension in the rat nutrient interactions . Comp Biochem Physiol A. 114:1996;327-333.
15. Langley S.C., Browne R.F., Jackson A.A. Altered glucose tolerance in rats exposed to maternal low protein diets in utero. Comp Biochem Physiol A. 109:1994;223-229.
16. Millanvoye-van Brussel E., Simon J., Freyss-Beguin M. Altered phospholipid fatty acid content and metabolism in heart cell cultures from newborn spontaneously hypertensive rats. Am J Hypertens. 7:1994;953-959.
17. Singer P., Wirth M., Godicke W., et al. Lipid levels and fatty acid pattern of triglycerides in liver of spontaneously hypertensive rats. Acta Biol Med Ger. 41:1982;811-817.
18. Singer P., Voigt S., Moritz V. Changes of polyunsaturated fatty acids in serum lipids of spontaneously hypertensive rats during the onset of high blood pressure. Prostaglandins Leukot Med. 12:1983;399-408.
19. Okamoto H., Kawaguchi H., Minami M., et al. Lipid alterations in renal membrane of stroke-prone spontaneously hypertensive rats. Hypertension. 13:1989;456-462.
20. Gidding S.S. Relationships between blood pressure and lipids in childhood. Pediatr Clin North Am. 40:1993;41-49.
21. Uiterwaal C.S., Witteman J.C., de Bruijn A.M., et al. Families and natural history of lipids in childhood an 18-year follow-up study . Am J Epidemiol. 145:1997;777-785.
22. Facchini F., Chen Y.D., Clinkingbeard C., et al. Insulin resistance, hyperinsulinemia, and dyslipidemia in nonobese individuals with a family history of hypertension. Am J Hypertens. 5:1992;694-699.
23. Lopes H.F., Silva H.B., Soares J.A., et al. Lipid metabolism alterations in normotensive subjects with positive family history of hypertension. Hypertension. 30:1997;629-631.
24. Hoffmann P. Cardiovascular actions of dietary polyunsaturates and related mechanisms. Prostaglandins Leukotrienes Med. 21:1986;113-147.
25. Knapp H.R. Omega-3 fatty acids, endogenous prostaglandins, and blood pressure regulation in humans. Nutr Rev. 47:1989;301-313.
26. Lee R.M. Fish oil, essential fatty acids, and hypertension. Can J Physiol Pharmacol. 72:1994;945-953.
27. Ollerenshaw J.D., Heagerty A.M., Bing R.F., Swales J.D. Abnormalities of erythrocyte membrane fatty acid composition in human essential hypertension. J Hum Hypertens. 1:1987;9-12.
28. + countertransport in essential hypertension correlation with membrane lipid levels . J Hypertens. 14:1996;969-973.
29. Russo C., Olivieri O., Girelli D., et al. Increased membrane ratios of metabolite to precursor fatty acid in essential hypertension. Hypertension. 29:1997;1058-1063.
30. Dominiczak A.F., Lazar D.F., Das A.K., Bohr D.F. Lipid bilayer in genetic hypertension. Hypertension. 18:1991;748-757.
31. Foucher C., Narce M., Nasr L., et al. Liver microsomal membrane fluidity and microsomal desaturase activities in adult spontaneously hypertensive rats. J Hypertens. 15:1997;863-869.
32. Dominiczak A.F., Davidson A.O., Bohr D.F. Plasma membrane in hypertension microviscosity and calcium stabilization . Hypertens Res. 17:1994;79-86.
33. Zachowski A. Phospholipids in animal eukaryotic membranes transverse asymmetry and movement . Biochem J. 294:1993;1-14.
34. Hubbell W.L., McConnell H.M. Molecular motion in spin-labeled phospholipids and membranes. J Am Chem Soc. 93:1971;314-326.
35. Prendergast F.G., Haugland R.P., Callahan P.J. 1-[4-(Trimethylamino)phenyl]-6-phenylhexa-1,3,5-triene synthesis, fluorescence properties, and use as a fluorescence probe of lipid bilayers . Biochemistry. 20:1981;7333-7338.
36. Mateo C.R., Lillo M.P., Gonzalez-Rodriguez J., Acuna A.U. Molecular order and fluidity of the plasma membrane of human platelets from time-resolved fluorescence depolarization. Eur Biophys J. 20:1991;41-52.
37. Saito H., Minamida T., Arimoto I., et al. Physical states of surface and core lipids in lipid emulsions and apolipoprotein binding to the emulsion surface. J Biol Chem. 271:1996;15515-15520.
38. Illinger D., Poindron P., Fonteneau P., et al. Internalization of the lipophilic fluorescent probe trimethylamino-diphenylhexatriene follows the endocytosis and recycling of the plasma membrane in cells. Biochim Biophys Acta. 1030:1990;73-81.
39. Bevers E.M., Verhallen P.F., Visser A.J., et al. Bidirectional transbilayer lipid movement in human platelets as visualized by the fluorescent membrane probe 1-[4-(trimethylammonio)phenyl]-6-phenyl-1,3,5-hexatriene. Biochemistry. 29:1990;5132-5137.
40. Kitagawa S., Matsubayashi M., Kotani K., et al. Asymmetry of membrane fluidity in the lipid bilayer of blood platelets fluorescence study with diphenylhexatriene and analogs . J Membr Biol. 119:1991;221-227.
41. Le Quan Sang K.H., Mazeaud M., Astarie C., et al. Plasma lipids and platelet membrane fluidity in essential hypertension. Thromb Haemost. 69:1993;70-76.
42. Caimi G., Lo Presti R., Montana M., et al. Platelet membrane fluidity and platelet membrane lipid pattern in essential hypertension. Am J Hypertens. 8:1995;82-86.
43. Dingley A.J., King N.J., King G.F. An NMR investigation of the changes in plasma membrane triglyceride and phospholipid precursors during the activation of T-lymphocytes. Biochemistry. 31:1992;9098-9106.
44. Muzulu S.I., Bing R.F., Norman R.I. Human erythrocyte membrane fluidity and calcium pump activity in primary combined hyperlipidaemia. Clin Sci. 88:1995;307-310.
45. Malle E., Gries A., Kostner G.M., et al. Is there any correlation between platelet aggregation, plasma lipoproteins, apoproteins and membrane fluidity of human blood platelets? Thromb Res. 53:1989;181-190.
46. Müller S., Ziegler O., Donner M., et al. Rheological properties and membrane fluidity of red blood cells and platelets in primary hyperlipoproteinemia. Atherosclerosis. 83:1990;231-237.
47. Miller M.A., Sagnella G.A., Markandu N.D., MacGregor G.A. Comparison of calcium, magnesium-ATPase activity and membrane fluidity in patients with essential hypertension and in normotensive controls. J Hypertens. 12:1994;929-938.
48. +-ATPase and membrane and serum lipid profiles as related to alcohol, body mass index and blood pressure . Clin Exp Hypertens. 16:1994;741-759.
49. Devynck M.A., Kuneš J., Le Quan Sang K.H., Zicha J. Membrane microviscosity and plasma triacylglycerols in the rat. Clin Sci. 94:1998;79-85.
50. Zicha J., Kuneš J., David-Dufilho M., et al. Cell calcium handling and intracellular pH regulation in hereditary hypertriglyceridemic rats reduced platelet response to thrombin stimulation . Life Sci. 59:1996;803-813.
51. Kuneš J., Mazeaud M.M., Devynck M.A., Zicha J. Platelet hypoaggregability in hereditary hypertriglyceridemic rats relation to plasma triglycerides . Thromb Res. 88:1997;347-353.
52. Carr P., Taub N.A., Watts G.F., Poston L. Human lymphocyte sodium-hydrogen exchange. The influences of lipids, membrane fluidity, and insulin. Hypertension. 21:1993;344-352.
53. Montenay-Garestier T., Aragon I., Devynck M.A., et al. Evidence for structural changes in erythrocyte membranes of spontaneously hypertensive rats. A fluorescence polarization study. Biochem Biophys Res Commun. 100:1981;660-665.
54. Devynck M.A., Pernollet M.G., Nunez A.M., et al. Diffuse structural alterations in cell membranes of spontaneously hypertensive rats. Proc Natl Acad Sci USA. 79:1982;5057-5060.
55. Orlov S.N., Gulak P.V., Litvinov I.S., Postnov Y.V. Evidence of altered structure of the erythrocyte membrane in spontaneously hypertensive rats. Clin Sci. 63:1982;43-45.
56. Tsuda K., Tsuda S., Minatogawa Y., et al. Decreased membrane fluidity of erythrocytes and cultured vascular smooth muscle cells in spontaneously hypertensive rats an electron spin resonance study . Clin Sci. 75:1988;477-480.
57. 2+ binding and membrane fluidity in essential and renal hypertension. Clin Sci. 63:1982;281-284.
58. Naftilan A.J., Dzau V.J., Loscalzo J. Preliminary observations on abnormalities of membrane structure and function in essential hypertension. Hypertension. 8:(suppl II):1986;II174-II179.
59. Tsuda K., Tsuda S., Minatogawa Y., et al. Membrane fluidity of erythrocytes and its relevance to renin profile in essential hypertension. Jpn Circ J. 52:1988;1301-1308.
60. Dominiczak A.F., McLaren Y., Kusel J.R., et al. Lateral diffusion and fatty acid composition in vascular smooth muscle membrane from stroke-prone spontaneously hypertensive rats. Am J Hypertens. 6:1993;1003-1008.
61. Aragon-Birlouez I., Montenay-Garestier T., Devynck M.A. Further analysis of cell membrane changes in genetic hypertension in rats by diphenylhexatriene fluorescence polarization. Clin Sci. 66:1984;717-723.
62. Daveloose D., Viret J., Molle D., Leterrier F. Mise en évidence, par marquage de spin, d'une modification structurale de la membrane érythrocytaire du rat génetiquement hypertendu. Structural modifications of the erythrocyte membrane in spontaneously hypertensive rats revealed by the spin label method . (in French) C R Seances Acad Sci Ser III Vie. 290:1980;85-88.
63. Aragon I., Montenay-Garestier T., Devynck M.A., et al. Diffuse structural abnormalities in cell membranes from genetically hypertensive rats a fluorescence study . Clin Sci. 63:(suppl 8):1982;49s-52s.
64. Le Quan Sang K.H., Kuneš J., Zicha J., et al. Platelet and erythrocyte membrane microviscosity in Lyon hypertensive rats. Am J Hypertens. 7:1994;276-281.
65. Kuneš J., Zicha J., Devynck M.A. Erythrocyte membrane microviscosity and blood pressure in rats with salt-induced and spontaneous hypertension. J Hypertens. 12:1994;229-234.
66. Jaiswal R.K., Landon E.J., Sastry B.V. Methylation of phospholipids in microsomes of the rat aorta. Biochim Biophys Acta. 735:1983;367-379.
67. 3 levels and intestinal brush border membrane fluidity . J Clin Invest. 78:1986;1083-1090.
68. Vazquez C.M., Zanetti R., Ruiz-Gutierrez V. Lipid composition and fluidity in the jejunal brush-border membrane of spontaneously hypertensive rats. Effects on activities of membrane-bound proteins. Biosci Rep. 16:1996;217-226.
69. Le Quan Sang K.H., Montenay-Garestier T., Devynck M.A. Alterations of platelet membrane microviscosity in essential hypertension. Clin Sci. 80:1991;205-211.
70. McLaren Y., Kreutz R., Lindpaintner K., et al. Membrane microviscosity does not correlate with blood pressure a cosegregation study . J Hypertens. 11:1993;25-30.
71. 2+-ATPase activity do not contribute to hypertension in the spontaneously hypertensive rat model. Clin Sci. 85:1993;585-591.
72. 2+ and membrane dynamics in patients with primary hypercholesterolemia. Effects of pravastatin. Arterioscler Thromb Vasc Biol. 15:1995;759-764.
73. Corrocher R., Ferrari S., Bassi A., et al. Membrane polyunsaturated fatty acids and lithium-sodium countertransport in human erythrocytes. Life Sci. 41:1987;1171-1178.
74. Rutherford P.A., Thomas T.H., Laker M.F., Wilkinson R. Plasma lipids affect maximum velocity not sodium affinity of human sodium-lithium countertransport distinction from essential hypertension . Eur J Clin Invest. 22:1992;719-724.
75. + binding and phospholipid composition in erythrocyte membranes of white hypertensive and normotensive individuals. A nuclear magnetic resonance investigation. Hypertension. 27:1996;456-464.
76. Corrocher R., Steinmayr M., Ruzzenente O., et al. Elevation of red cell sodium-lithium countertransport in hyperlipidemias. Life Sci. 36:1985;649-655.
77. Carr S.J., Thomas T.H., Laker M.F., Wilkinson R. Elevated sodium-lithium countertransport a familial marker of hyperlipidaemia and hypertension? J Hypertens. 8:1990;139-146.
78. Strazzullo P., Cappuccio F.P., Trevisan M., et al. The relationship of erythrocyte sodium-lithium countertransport to blood pressure and metabolic abnormalities in a sample of untreated middle-aged male workers. J Hypertens. 11:1993;815-822.
79. Pagnan A., Corrocher R., Ambrosio G.B., et al. Effects of an olive-oil-rich diet on erythrocyte membrane lipid composition and cation transport systems. Clin Sci. 76:1989;87-93.
80. Corrocher R., Pagnan A., Ambrosio G.B., et al. Effects induced by olive oil-rich diet on erythrocytes membrane lipids and sodium-potassium transports in postmenopausal hypertensive women. J Endocrinol Invest. 15:1992;369-376.
81. Lijnen P., Fagard R., Staessen J., et al. Erythrocyte membrane lipids and cationic transport systems in men. J Hypertens. 10:1992;1205-1211.
82. Muriana F.J., Villar J., Ruiz-Gutierrez V. Erythrocyte membrane cholesterol distribution in patients with untreated essential hypertension correlation with sodium-lithium countertransport . J Hypertens. 14:1996;443-446.
83. Engelmann B., Duhm J., Schönthier U.M., Streich S. Relations of sodium-lithium countertransport kinetics to plasma and red cell membrane phospholipids in hyperlipidemia. Atherosclerosis. 99:1993;151-163.
84. + countertransport in vivo and in vitro evidence . J Membr Biol. 133:1993;99-106.
85. + pump in hyperlipidemia is related to increase in 1-palmitoyl,2-arachidonoyl-plasmalogen phosphatidylethanolamine. Biochim Biophys Acta. 1149:1993;185-188.
86. Dwight J.F., Hendry B.M. Effects of membrane incorporation of short-chain phospholipids on sodium pump function in human erythrocytes. Clin Chim Acta. 243:1995;73-85.
87. Engelmann B., Op den Kamp J.A., Roelofsen B. Replacement of molecular species of phosphatidylcholine influence on erythrocyte Na transport . Am J Physiol. 258:1990;C682-C691.
88. Robertson D.A., Heagerty A.M., Ollerenshaw J.D., Swales J.D. Linoleic acid supplementation, membrane lipids and leucocyte sodium transport in normotensive humans. J Hum Hypertens. 3:1989;117-123.
89. Cooper R.A. Abnormalities of cell membrane fluidity in the pathogenesis of disease. N Engl J Med. 297:1977;371-377.
90. Dowd A., Thomas T.H., Wilkinson R. Increased human erythrocyte sodium-lithium countertransport in hyperlipidaemic patients may indicate increased membrane lipid fluidity. Eur J Clin Invest. 23:1993;102-107.
91. Carr S.J., Sikand K., Moore D., Norman R.I. Altered membrane microviscosity in essential hypertension relationship with family history of hypertension and sodium-lithium countertransport activity . J Hypertens. 13:1995;139-146.
92. + cotransport in essential hypertension, primary hyperaldosteronism, and hypokalemia. Scand J Clin Lab Invest. 46:(suppl 180):1986;82-95.
93. Hunt S.C., Williams R.R., Smith J.B., Ash K.O. Associations of three erythrocyte cation transport systems with plasma lipids in Utah subjects. Hypertension. 8:1986;30-36.
94. Hespel P., Lijnen P., Fagard R., et al. Changes in erythrocyte sodium and plasma lipids associated with physical training. J Hypertens. 6:1988;159-166.
95. Hajem S., Moreau T., Hannaert P., et al. Erythrocyte cation transport systems and plasma lipids in a general male population. J Hypertens. 8:1990;891-896.
96. Zicha J. Red cell ion transport abnormalities in experimental hypertension. Fundam Clin Pharmacol. 7:1993;129-141.
97. De Mendonca M., Knorr A., Grichois M.L., et al. Erythrocytic sodium ion transport systems in primary and secondary hypertension of the rat. Kidney Int. 21:(suppl 11):1982;S69-S75.
98. Ferrari P., Ferrandi M., Torielli L., et al. Relationship between erythrocyte volume and sodium transport in the Milan hypertensive rat and age-dependent changes. J Hypertens. 5:1987;199-206.
99. + transport in red blood cells of Dahl rats. Effects of age and salt. Hypertension. 15:1990;612-627.
100. Vincent M., Sacquet J., Sassard J. The Lyon strains of hypertensive, normotensive and low-blood-pressure rats. De Jong W., Handbook of Hypertension, Vol 4: Experimental and Genetic Models of Hypertension. 1984;314-327 Elsevier, Amsterdam.
101. Sassolas A., Vincent M., Benzoni D., Sassard J. Plasma lipids in genetically hypertensive rats of the Lyon strain. J Cardiovasc Pharmacol. 3:1981;1008-1014.
102. Vrána A., Kazdová L. The hereditary hypertriglyceridemic nonobese rat an experimental model of human hypertriglyceridemia . Transplant Proc. 22:1990;2579.
103. Štolba P., Dobešová Z., Hušek P., et al. The hypertriglyceridemic rat as a genetic model of hypertension and diabetes. Life Sci. 51:1992;733-740.
104. Zicha J., Dobešová Z., Kuneš J. Plasma triglycerides and red cell ion transport alterations in genetically hypertensive rats. Hypertension. 30:1997;636-640.
105. Friedman S.M., Nakashima M., McIndoe R.A., Friedman C.L. Increased erythrocyte permeability to Li and Na in the spontaneously hypertensive rat. Experientia. 32:1976;476-478.
106. Postnov Y.V., Orlov S., Gulak P., Shevchenko A. Altered permeability of the erythrocyte membrane for sodium and potassium ions in spontaneously hypertensive rats. Pflügers Arch. 365:1976;257-263.
107. Bin Talib H.K., Dobešová Z., Klír P., et al. Association of red blood cell sodium leak with blood pressure in recombinant inbred strains. Hypertension. 20:1992;575-582.
108. Giraud F., Claret M., Garay R. Interactions of cholesterol with the Na pump in red blood cells. Nature. 264:1976;646-648.
109. Claret M., Garay R., Giraud F. The effect of membrane cholesterol on the sodium pump in red blood cells. J Physiol Lond. 274:1978;247-263.
110. Lijnen P., Celis H., Fagard R., et al. Influence of cholesterol lowering on plasma membrane lipids and cationic transport systems. J Hypertens. 12:1994;59-64.
111. Lijnen P., Petrov V. Cholesterol modulation of transmembrane cation transport systems in human erythrocytes. Biochem Mol Med. 56:1995;52-62.
112. o countertransport and Li leak in erythrocytes are differentially affected by membrane enrichment with cholesteryl hemisuccinate. Biochim Biophys Acta. 854:1986;325-328.
113. Lijnen P., Fenyvesi A., Bex M., et al. Erythrocyte cation transport systems and membrane lipids in insulin-dependent diabetes. Am J Hypertens. 6:1993;763-770.
114. Wiley J.S., Cooper R.A. Inhibition of cation cotransport by cholesterol enrichment of human red cell membranes. Biochim Biophys Acta. 413:1975;425-431.
115. Jelicks L.A., Gupta R.K. NMR measurement of cytosolic free calcium, free magnesium, and intracellular sodium in the aorta of the normal and spontaneously hypertensive rat. J Biol Chem. 265:1990;1394-1400.
116. Sada T., Koike H., Ikeda M., et al. Cytosolic free calcium of aorta in hypertensive rats. Chronic inhibition of angiotensin converting enzyme. Hypertension. 16:1990;245-251.
117. Touyz R.M., Tolloczko B., Schiffrin E.L. Mesenteric vascular smooth muscle cells from spontaneously hypertensive rats display increased calcium responses to angiotensin II but not to endothelin-1. J Hypertens. 12:1994;663-673.
118. 2+] is increased in the platelets of spontaneously hypertensive rats and essential hypertensive patients. Clin Sci. 68:1985;179-184.
119. Oshima T., Young E.W., Bukoski R.D., McCarron D.A. Abnormal calcium handling by platelets of spontaneously hypertensive rats. Hypertension. 15:1990;606-611.
120. 2+ handling in the spontaneously hypertensive rat effect of vanadate ions . Life Sci. 54:1994;267-274.
121. i increased in blood cells in primary hypertension? J Hypertens. 3:(suppl 3):1985;S45-S47.
122. Tepel M., Husseini S., Wischniowski H., Zidek W. Effect of inhibition of Na, K-ATPase on cytosolic free sodium and calcium in platelets of spontaneously hypertensive rats. Am J Hypertens. 5:1992;740-743.
123. Zicha J., Pernollet M.G., Kuneš J., et al. Alterations of cytosolic calcium in platelets and erythrocytes of Lyon hypertensive rats. Am J Hypertens. 8:1995;842-849.
124. Ishida T., Ishida M., Matsuura H., et al. Dietary salt decreases cytosolic calcium in platelets from Dahl salt-sensitive rats. Am J Physiol. 269:1995;R1225-R1229.
125. Zicha J., Kuneš J., Devynck M.A. Platelet calcium handling is different in rats with salt-dependent and spontaneous forms of genetic hypertension. Am J Hypertens. 9:1996;812-818.
126. Erne P., Bolli P., Bürgisser E., Bühler F.R. Correlation of platelet calcium with blood pressure. Effect of antihypertensive therapy. N Engl J Med. 310:1984;1084-1088.
127. 2+ concentration and plasma cholesterol in untreated hypertensives. J Hypertens. 5:(suppl 5):1987;S251-S254.
128. Lechi A., Lechi C., Bonadonna G., et al. Increased basal and thrombin-induced free calcium in platelets of essential hypertensive patients. Hypertension. 9:1987;230-235.
129. Oshima T., Matsuura H., Kido K., et al. Intralymphocytic sodium and free calcium and plasma renin in essential hypertension. Hypertension. 12:1988;26-31.
130. Alexiewicz J.M., Gaciong Z., Parise M., et al. Effect of dietary sodium intake on intracellular calcium in lymphocytes of salt-sensitive hypertensive patients. Am J Hypertens. 5:1992;536-541.
131. Rivera A., Conlin P.R., Williams G.H., Canessa M.L. Elevated lymphocyte cytosolic calcium in a subgroup of essential hypertensive subjects. Hypertension. 28:1996;213-218.
132. Resnick L.M., Gupta R.K., Bhargava K.K., et al. Cellular ions in hypertension, diabetes, and obesity. A nuclear magnetic resonance spectroscopic study. Hypertension. 17:1991;951-957.
133. 2+ concentration in essential hypertension. Hypertension. 19:1992;167-174.
134. Lindner A., Hinds T.R., Davidson R.C., Vincenzi F.F. Increased cytosolic free calcium in red blood cells is associated with essential hypertension in humans. Am J Hypertens. 6:1993;771-779.
135. Kwan C.Y. Dysfunction of calcium handling by smooth muscle in hypertension. Can J Physiol Pharmacol. 63:1985;366-374.
136. Bohr D.F., Webb R.C. Vascular smooth muscle membrane in hypertension. Annu Rev Pharmacol Toxicol. 28:1988;389-409.
137. Dominiczak A.F., Bohr D.F. Cell membrane abnormalities and the regulation of intracellular calcium concentration in hypertension. Clin Sci. 79:1990;415-423.
138. Rusch N.J., Hermsmeyer K. Calcium currents are altered in the vascular muscle cell membrane of spontaneously hypertensive rats. Circ Res. 63:1988;997-1002.
139. 2+ channels in resistance arteries from spontaneously hypertensive rats. Circ Res. 73:1993;1090-1099.
140. + channels in resting state of femoral arteries from spontaneously hypertensive rats at prehypertensive stage. J Pharmacol Exp Ther. 275:1995;775-783.
141. Bialecki R.A., Tulenko T.N., Colucci W.S. Cholesterol enrichment increases basal and agonist-stimulated calcium influx in rat vascular smooth muscle cells. J Clin Invest. 88:1991;1894-1900.
142. Sen L., Bialecki R.A., Smith E., et al. Cholesterol increases the L-type voltage-sensitive calcium channel current in arterial smooth muscle cells. Circ Res. 71:1992;1008-1014.
143. Gleason M.M., Medow M.S., Tulenko T.N. Excess membrane cholesterol alters calcium movements, cytosolic calcium levels, and membrane fluidity in arterial smooth muscle cells. Circ Res. 69:1991;216-227.
144. Furspan P.B., Jokelainen P.T., Sing C.F., Bohr D.F. Genetic relationship between a lymphocyte membrane abnormality and blood pressure in spontaneously hypertensive stroke prone and Wistar-Kyoto rats. J Hypertens. 5:1987;293-297.
145. Lamb F.S., Myers J.H., Hamlin M.N., Webb R.C. Oscillatory contractions in tail arteries from genetically hypertensive rats. Hypertension. 7:(suppl I):1985;I25-I30.
146. Mulvany M.J. Possible role of vascular oscillatory activity in the development of high blood pressure in spontaneously hypertensive rats. J Cardiovasc Pharmacol. 12:(suppl 6):1988;S16-S20.
147. Bruner C.A., Myers J.H., Sing C.F., et al. Genetic association of hypertension and vascular changes in stroke-prone spontaneously hypertensive rats. Hypertension. 8:1986;904-910.
148. Lamb F.S., Moreland R.S., Webb R.C. Calcium and contractile responses to ouabain and potassium-free solution in aortae from spontaneously hypertensive rats. J Hypertens. 6:1988;821-828.
149. Morita S., Iwasaki T., Nagai K., et al. Ouabain-induced contraction of vascular smooth muscle in spontaneously hypertensive rats and the effect of hydralazine. Eur J Pharmacol. 151:1988;409-418.
150. Bruner C.A., Myers J.H., Sing C.F., et al. Genetic basis for altered vascular responses to ouabain and potassium-free solution in hypertension. Am J Physiol. 251:1986;H1276-H1282.
151. 2+ is not coinherited with an inferred major gene locus for hypertension (ht) in the spontaneously hypertensive rat. Am J Hypertens. 10:1997;282-288.
152. Vincent M., Samani N.J., Gauguier D., et al. A pharmacogenetic approach to blood pressure in Lyon hypertensive rats. Chromosome 2 locus influences the response to a calcium antagonist. J Clin Invest. 100:1997;2000-2006.
153. Vincent M., Boussairi E.H., Cartier R., et al. High blood pressure and metabolic disorders are associated in the Lyon hypertensive rat. J Hypertens. 11:1993;1179-1185.
154. Vincent M., Cartier R., Privat P., et al. Major cardiovascular risk factors in Lyon hypertensive rats. A correlation analysis in a segregating population. J Hypertens. 14:1996;469-474.
155. Kuneš J., Dobešová Z., Zicha J. High blood pressure of hypertriglyceridemic rats is related to metabolic disturbances. Physiol Res. 44:1995;421-424.
156. Zicha Dobe, šová Z., Kuneš J. Plasma triglycerides cosegregate with erythrocyte sodium content in F2 rats of HTG × Lewis cross. Physiol Res. 44:1995;425-428.
157. Sachinidis A., Locher R., Steiner A., et al. Effect of low-density lipoprotein on intracellular calcium, intracellular pH and DNA synthesis in cultured vascular smooth muscle cells. J Hypertens. 7:(suppl 6):1989;S116-S117.
158. Resink T.J., Rybin V., Bernhardt J., et al. Cellular signalling by lipoproteins in cultured smooth muscle cells from spontaneously hypertensive rats. J Vasc Res. 30:1993;169-180.
159. Bühler F.R., Tkachuk V.A., Hahn A.W., Resink T.J. Low- and high-density lipoproteins as hormonal regulators of platelet, vascular endothelial and smooth muscle cell interaction relevance to hypertension . J Hypertens. 9:(suppl 6):1991;S28-S36.
160. Locher R., Knorr M., Edmonds D., et al. Influence of cholesterol on intracellular free calcium concentration in human platelets. J Hypertens. 4:(suppl 6):1986;S358-S360.
161. Miller M.A., Sagnella G.A., Markandu N.D., MacGregor G.A. Determinants of platelet intracellular free calcium in essential hypertension and effect of stimulation by arginine vasopressin. Am J Hypertens. 6:1993;209-216.
162. Le Quan Sang K.H., Levenson J., Simon A., Devynck M.A. Platelet cytosolic calcium concentration, plasma lipids and hypertension. J Hypertens. 13:1995;1575-1580.
163. Knorr M., Locher R., Vogt E., et al. Rapid activation of human platelets by low concentrations of low-density lipoprotein via phosphatidylinositol cycle. Eur J Biochem. 172:1988;753-759.
164. Passfall J., Philipp T., Woermann F., et al. Different effects of eicosapentaenoic acid and olive oil on blood pressure, intracellular free platelet calcium, and plasma lipids in patients with essential hypertension. Clin Investig. 71:1993;628-633.
165. Hamilton J.A. Interactions of triglycerides with phospholipids incorporation into the bilayer structure and formation of emulsions . Biochemistry. 28:1989;2514-2520.
166. Engelmann B., Streich S., Schönthier U.M., et al. Changes of membrane phospholipid composition of human erythrocytes in hyperlipidemias. I. Increased phosphatidylcholine and reduced sphingomyelin in patients with elevated levels of triacylglycerol-rich lipoproteins. Biochim Biophys Acta. 1165:1992;32-37.
167. Aalkjaer C. Regulation of intracellular pH and its role in vascular smooth muscle function. J Hypertens. 8:1990;197-206.
168. Batlle D., Redon J., Gutterman C., et al. Acid-base status and intracellular pH regulation in lymphocytes from rats with genetic hypertension. J Am Soc Nephrol. 5:(suppl 1):1994;S12-S22.
169. Sharma A.M., Distler A. Acid-base abnormalities in hypertension. Am J Med Sci. 307:(suppl 1):1994;S112-S115.
170. Lucas P.A., Lacour B., McCarron D.A., Drüeke T. Disturbance of acid-base balance in the young spontaneously hypertensive rat. Clin Sci. 73:1987;211-215.
171. Batlle D.C., Sharma A.M., Alsheikha M.W., et al. Renal acid excretion and intracellular pH in salt-sensitive genetic hypertension. J Clin Invest. 91:1993;2178-2184.
172. Rosskopf D., Düsing R., Siffert W. Membrane sodium-proton exchange and primary hypertension. Hypertension. 21:1993;607-617.
173. Izzard A.S., Cragoe E.J. Jr, Heagerty A.M. Intracellular pH in human resistance arteries in essential hypertension. Hypertension. 17:1991;780-786.
174. Resnick L.M., Gupta R.K., Sosa R.E., et al. Intracellular pH in human and experimental hypertension. Proc Natl Acad Sci USA. 84:1987;7663-7667.
175. + exchanger activity and NHE-1 mRNA expression in lymphocytes from patients with essential hypertension. Hypertension. 25:1995;356-364.
176. + antiport activity in human hypertension. J Hypertens. 7:1989;471-475.
177. Astarie C., Levenson J., Simon A., et al. Platelet cytosolic proton and free calcium concentrations in essential hypertension. J Hypertens. 7:1989;485-491.
178. Lechi C., Guzzo P., Arosio E., et al. Early agonist-induced intracellular acidification is increased in platelets from patients with essential hypertension. Am J Hypertens. 7:1994;1090-1096.
179. + exchange and other ion-transport systems in erythrocytes of essential hypertensives and spontaneously hypertensive rats a comparative analysis . J Hypertens. 7:1989;781-788.
180. Canessa M., Morgan K., Goldszer R., et al. Kinetic abnormalities of the red blood cell sodium-proton exchange in hypertensive patients. Hypertension. 17:1991;340-348.
181. - anion exchanger in erythrocytes of patients with essential hypertension. J Hypertens. 10:1992;579-585.
182. Alonso A., Arrazola A., Garciandia A., et al. Erythrocyte anion exchanger activity and intracellular pH in essential hypertension. Hypertension. 22:1993;348-356.
183. Tokudome G., Tomonari H., Gardner J.P., et al. Variations in the apparent pH set point for activation of platelet Na-H antiport. Hypertension. 16:1990;180-189.
184. + exchange rate and more alkaline intracellular pH set-point in essential hypertension effects of protein kinase modulation in platelets . J Hypertens. 9:1991;1013-1019.
185. Zentay Z., Reddi A., Raguwanshi M., et al. Platelet sodium-hydrogen antiport in obese and diabetic black women. Hypertension. 20:1992;549-554.
186. Poli de Figueiredo C.E., Ng L.L., Davies J.E., et al. Modulation of Na-H antiporter activity in human lymphoblasts by altered membrane cholesterol. Am J Physiol. 261:1991;C1138-C1142.
187. + exchange within human platelets. FEBS Lett. 299:1992;19-22.
188. + antiport in human platelets. Thromb Haemost. 75:1996;635-641.
189. + antiport in human platelets. A novel mechanism enhancing platelet activity in hypercholesterolemia. Circulation. 95:1997;1370-1377.
190. Tamagaki T., Sawada S., Imamura H., et al. Effects of high-density lipoproteins on intracellular pH and proliferation of human vascular endothelial cells. Atherosclerosis. 123:1996;73-82.
191. Weder A.B., Serr C., Torretti B.A., et al. Effects of lovastatin treatment on red blood cell and platelet cation transport. Hypertension. 17:1991;203-209.
192. Falkner B., Canessa M., Anzalone D. Effect of angiotensin converting enzyme inhibitor (lisinopril) on insulin sensitivity and sodium transport in mild hypertension. Am J Hypertens. 8:1995;454-460.
193. + exchange activity in essential hypertension an in vitro study under physiological conditions . J Hypertens. 9:1991;645-653.
194. + antiport activity in diabetic nephropathy. Kidney Int. 41:1992;872-876.
195. Astarie C., Le Quan Sang K.H., David-Dufilho M., Devynck M.A. Further investigation of platelet cytosolic alkalinization in essential hypertension. J Hypertens. 10:1992;849-854.
196. Batlle D.C., Saleh A., Rombola G. Reduced intracellular pH in lymphocytes from the spontaneously hypertensive rat. Hypertension. 15:1990;97-103.
197. Redon J., Batlle D. Regulation of intracellular pH in the spontaneously hypertensive rat. Role of bicarbonate-dependent transporters. Hypertension. 23:1994;503-512.
198. Tepel M., Klaus T., Laukemper S., Zidek W. Reduced sodium-proton exchange activity in lymphocytes from transgenic rats. Hypertension. 24:1994;357-361.
199. Zicha J., Kuneš J., Ben-Ishay D., Devynck M.A. Abnormal regulation of cytosolic calcium and pH in platelets of Sabra rats in early phases of salt hypertension development. Can J Physiol Pharmacol. 74:1996;1222-1228.
200. Zicha J., David-Dufilho M., Kuneš J., et al. Cytosolic pH and calcium in Dahl salt-sensitive and salt-resistant rats the relationship to plasma lipids . J Hypertens. 15:1997;1715-1721.
201. + exchange in platelets from spontaneously hypertensive rats. Hypertension. 28:1996;1013-1017.
202. + exchange. J Clin Invest. 83:1989;822-829.
203. Izzard A.S., Heagerty A.M. The measurement of internal pH in resistance arterioles evidence that intracellular pH is more alkaline in SHR than WKY animals . J Hypertens. 7:1989;173-180.
204. + antiporter (NHE-1 isoform) in cultured vascular smooth muscle from the spontaneously hypertensive rat. Kidney Int. 47:1995;78-87.
205. Scuteri A., Jensen P.E., Aalkjaer C. The regulation of pH in resistance arteries from spontaneously hypertensive and Wistar-Kyoto rats the effect of bicarbonate . J Hypertens. 13:1995;523-528.
206. + exchange in mesenteric arteries from spontaneously hypertensive rats. Am J Physiol. 262:1992;H1657-H1662.
207. + exchange activity in cultured vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats. J Hypertens. 8:1990;153-157.
208. Izzard A.S., Heagerty A.M. Resting intracellular pH in mesenteric resistance arteries from spontaneously hypertensive and Wistar-Kyoto rats effects of amiloride and 4,4′-diisothiocyanatostilbene-2,2′-disulphonic acid . J Hypertens. 7:(suppl 6):1989;S128-S129.
209. Feig P.U., D'Occhio M.A., Boylan J.W. Lymphocyte membrane sodium-proton exchange in spontaneously hypertensive rats. Hypertension. 9:1989;282-288.
210. Feig P.U. Increased platelet membrane sodium-proton exchange rate in spontaneously hypertensive rats. Am J Hypertens. 3:1990;927-932.
211. + antiport activity in cultured skeletal muscle cells and vascular smooth muscle cells from the spontaneously hypertensive rat. Clin Sci. 80:1991;509-516.
212. + exchange in vascular smooth muscle cells from WKY and SHR effects of phorbol ester . Am J Physiol. 268:1995;C14-C20.
213. Orlov S.N., Petrunyaka V.V., Pokudin N.I., et al. Cation transport and adenosine triphosphatase activity in rat erythrocytes a comparison of spontaneously hypertensive rats with the normotensive Brown-Norway strain . J Hypertens. 9:1991;977-982.
214. 1A dopamine receptor in the pathogenesis of genetic hypertension. J Clin Invest. 97:1996;2283-2288.
215. + antiporter as a candidate gene in human essential hypertension. Hypertension. 17:1991;8-14.
216. Koh E., Morimoto S., Nabata T., et al. The action of low density lipoprotein on vascular smooth muscle cells involves increase in intracellular pH. Biochem Int. 20:1990;127-133.
217. Sachinidis A., Locher R., Mengden T., Vetter W. Low-density lipoprotein elevates intracellular calcium and pH in vascular smooth muscle cells and fibroblasts without mediation of LDL receptor. Biochem Biophys Res Commun. 167:1990;353-359.